Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nostrum Biodiscovery has enabled the discovery of new chemical entities in cardiovascular disease and other areas through its proprietary computational platforms. Its technology has been validated in multiple industrial collaborations with successful case studies published with partners like ESTEVE, Almirall, Janssen Pharmaceutica, and Emerald. The company focuses on accelerating hit finding and hit-to-lead optimization using advanced AI-driven molecular modeling tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nostrum Biodiscovery.